MedTrace Logo

Early Versus Late Lactoferrin in Prevention of Neonatal Sepsis

NCT02959229 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2016-11-09

No results posted yet for this study

Summary

The present study was designed to evaluate the effectiveness of oral lactoferrin in prevention of neonatal sepsis with comparison early (1st day) versus late (48-72 hours) Lactoferrin administration, Secondary aim was to study effect of Lactoferrin administration on serum Ferritin and follow up long term outcome (Bronchopulmonary dysplasia, retinopathy of prematurity and necrotizing enterocolitis.

Conditions

  • Neonatal Sepsis

Interventions

DRUG

Lactoferrin

DRUG

Placebo (for Lactoferrin)

placebo in form of distilled water

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Ghada I Ghad, Professor · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
3 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-12-31
Completion
2016-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02959229 on ClinicalTrials.gov